Search Results for: ustr

USTR recently asked KEI if there were areas in the IP Chapter where we approved of the positions taken by USTR, and the answer is, yes. Given how critical we have been about the text, I will mention a few here.

USTR now “supports a more flexible approach under which partners could retain reasonable patent pre-grant opposition procedures.” This is welcome, and useful.

Continue Reading →

In a December 2, 2013 letter, Senator Orrin Hatch wrote to USTR’s Michael Froman, suggesting TPP exclude any countries that do not meet “high levels of ambition.” According to Hatch, these high ambitions include agreeing to 12 years of exclusive rights for IPR in biologic drug test data, and the elimination of barriers to cross border data flows (a privacy issue). A copy of the Hatch letter is attached below.

The timing of the Hatch letter is designed to pressure countries meeting in Singapore on December 7-10 in the TPP negotiation, on these two contentious issues.

Continue Reading →

KEI has asked 21 persons following the TPP IPR negotiations, what they thought of four of the USTR negotiators, including:

• Ambassador and USTR head Michael Froman,
• TPP Chief negotiator Barbara Weisel
• Assistant USTR for Intellectual Property and Innovation Stanford McCoy, and
• Deputy Assistant USTR for Intellectual Property and Innovation Probir Mehta.

Continue Reading →

On 7-8 August 2013, the Department of Trade and Industry (the DTI), Republic of South Africa and the World Trade Organization (WTO), in close collaboration with the World Health Organization (WHO) and the World Intellectual Property Organization (WIPO) will hold a National Workshop on Intellectual Property and Public Health in Pretoria. Leading experts from these intergovernmental organizations, Roger Kampf (WTO), Dr. Continue Reading →

22 July 2013

This was the statement delivered by Australia (Ian Goss, General Manager, IP Australia) on Monday, 22 July 2013.

Australian Statement

Thank you chair

Firstly, I will begin with a negative, last week was perhaps the most frustrating of our meetings this year, in contrast to significant progress on Gr’s [genetic resources] with disclosure proponents agreeing on an administrative approach to disclosure rather than substantive examination, this was a significant shift in position from a number key countries.

Continue Reading →

A PDF version of our comments is available here.

People have until midnight May 10, 2013 to file comments, here:
http://www.regulations.gov/#!documentDetail;D=USTR-2013-0019-0001

This is the table of contents.

Comments on the Administration’s Intention to Enter Into Negotiations for the Transatlantic Trade and Investment Partnership (TTIP) Agreement
Response to Docket No. USTR-2013-0019

Introduction
Transparency
Continue Reading →